AG真人官方

Clean Harbors, Inc. (CLH) 鈥� Form 4 insider filing: Co-CEO and Director Michael L. Battles reported one transaction dated July 1, 2025.

• Transaction code F indicates the disposition of shares withheld by the company to satisfy tax obligations that arose upon the vesting of equity awards.
• Shares disposed: 1,532 common shares at an effective price of $229.55 per share.
• Post-transaction ownership: Battles now directly holds 80,911 CLH common shares, which already includes 14 shares acquired through the Employee Stock Purchase Plan on June 30, 2025.

The filing reflects an administrative, cashless tax-withholding event rather than an open-market sale or purchase; therefore, it carries limited signal about management鈥檚 view of the company鈥檚 prospects.

PDF Solutions, Inc. (PDFS) 鈥� Form 4 insider filing

Chief Technology Officer Andrzej Strojwas reported an internal share transaction dated 01 July 2025. The filing shows a disposition of 2,497 common shares at a price of $21.87 each, coded 鈥淔,鈥� which indicates the shares were automatically surrendered to the company solely to cover federal and state tax-withholding obligations triggered by the vesting of restricted stock units (RSUs). No shares were sold into the open market.

Following the withholding transaction, Strojwas鈥� direct ownership stands at 83,613 common shares. This figure already includes 479 shares purchased on 31 Jan 2025 under the company鈥檚 Employee Stock Purchase Plan. No derivative securities were involved or reported.

The transaction is routine, does not signal a discretionary sale, and does not materially change insider ownership levels or imply a change in strategic outlook.

JPMorgan Chase Financial Company LLC is offering Leveraged Market-Linked Step Up Notes maturing in July 2027 that are linked to a six-index international equity basket. The basket is weighted 40% EURO STOXX 50, 20% FTSE 100, 20% Nikkei 225, 7.5% Swiss Market Index, 7.5% S&P/ASX 200 and 5% FTSE China 50, making European performance鈥攑articularly the EURO STOXX 50鈥攖he largest driver of returns.

Return profile at maturity

• If the basket is flat or higher, holders receive the greater of: (a) principal plus a Step Up Payment of 16鈥�18% ($1.60鈥�$1.80 per $10 unit) or (b) principal plus 150% of the positive basket return.
• If the basket declines, investors incur a 1-for-1 loss of principal鈥攗p to total loss鈥攂ased solely on the final basket level.

Key structural terms

• Denomination: $10 per unit; minimum initial order of 10,000 units.
• Tenor: approximately 2 years.
• Issuer credit: unsecured note of JPMorgan Chase Financial Company LLC; fully and unconditionally guaranteed by JPMorgan Chase & Co.
• Fees: $0.20 per unit (sales commission $0.15; structuring fee $0.05).
• Initial estimated value: $9.50鈥�$9.715, below the $10 public offering price due to embedded fees and internal funding assumptions.
• Secondary market: none expected; JPMS may offer limited, uncommitted liquidity.

Risk highlights

• Full downside market exposure with no principal protection.
• Performance measured only on the Final Calculation Day; interim gains can be lost.
• Credit risk of both issuer and guarantor; notes are not FDIC-insured.
• Potential conflict of interest as JPMS is calculation agent and hedging counterparty.
• Estimated value discount and fees create negative carry for investors exiting early.

The product suits investors with a bullish or neutral two-year view on the basket who can tolerate full loss of principal, forgo dividends and accept limited liquidity in exchange for enhanced upside participation and a defined minimum positive return.

Leidos Holdings, Inc. (LDOS) 鈥� Form 4 insider transaction

Chief Financial Officer Christopher R. Cage reported one transaction dated 06/30/2025.

• Acquisition: 64.1944 shares of common stock credited at $0.00 per share. The shares represent dividend-equivalent rights that were automatically reinvested in the company鈥檚 Key Executive Stock Deferral Plan.
• Post-transaction ownership: 29,288.682 indirect shares held via the deferral plan and 46,953 direct shares.

No derivative securities were involved and no sales were disclosed. The filing does not indicate any open-market purchases or dispositions; the recorded activity is routine and non-cash. Given the immaterial share amount relative to the executive鈥檚 existing holdings, the filing is unlikely to have a meaningful impact on LDOS鈥檚 share count or market perception.

ZoomInfo Technologies Inc. (ZI) 鈥� Form 144 filing discloses a planned insider sale under Rule 144.

• Securities to be sold: 14,773 Class A common shares.
• Estimated market value: US$148,911.84 (based on prevailing market price cited in the form).
• Seller of record: James M. Roth, acting pursuant to a Rule 10b5-1 trading plan, with Morgan Stanley Smith Barney LLC as broker.
• Planned sale date: on or about 02 July 2025 through NASDAQ.
• Share-count context: ZI reports 328,911,200 shares outstanding; the proposed sale represents 鈮�0.0045 % of shares outstanding.
• Recent activity: The same insider sold 18,408 shares on 05 June 2025 for gross proceeds of US$184,398.72.

The filing is a routine notice rather than a completed transaction. Given the small size relative to total float, the event is unlikely to be materially impactful for shareholders, but it does provide visibility into insider trading activity and possible sentiment.

Form 8-K Highlights: Hyperion DeFi, Inc. (formerly Eyenovia, Inc.) filed a current report covering two principal matters: (1) departure of its Chief Operating Officer and (2) a corporate name and ticker change.

Executive departure (Item 5.02): Effective July 1, 2025, COO Bren Kern鈥檚 employment terminated in connection with a previously announced reduction-in-force. Under a Separation and Release Agreement, he will receive 12 months of base salary and up to 12 months of continued health-care benefits, conditioned upon standard release and covenant provisions. The agreement is attached as Exhibit 10.1.

Name and ticker change (Item 5.03): A Certificate of Amendment filed June 30, 2025, changed the company鈥檚 legal name from Eyenovia, Inc. to Hyperion DeFi, Inc., effective 8:00 a.m. ET on July 1, 2025. Board approval under Delaware General Corporation Law 搂242 was sufficient; no stockholder vote was required. Common shares retain the same rights and CUSIP, but the Nasdaq ticker will convert from 鈥淓YEN鈥� to 鈥淗YPD鈥� beginning July 3, 2025.

Reg FD disclosure (Item 7.01): A press release regarding the rebrand and ticker change was furnished (Exhibit 99.1) and is not deemed 鈥渇iled鈥� for Exchange Act liability.

Exhibits:

• 3.1 鈥� Certificate of Amendment (Name Change)
• 10.1 鈥� Separation and Release Agreement (COO)
• 99.1 鈥� Press Release announcing changes
• 104 鈥� Inline XBRL cover page

The filing is primarily administrative; it signals a strategic rebranding without altering share structure, while simultaneously disclosing senior management turnover that may raise continuity concerns.

Form 4 filing overview: On 06/30/2025, MAIA Biotechnology, Inc. (ticker MAIA) granted director Cristian Luput a package of stock options under the company鈥檚 2021 Equity Incentive Plan.

• Options granted: 21,350 options to purchase common shares.
• Exercise price: $1.80 per share.
• Vesting schedule: 100% vested immediately on the grant date.
• Expiration: 06/30/2035 (10-year term).
• Post-transaction holdings: Luput now holds 21,350 derivative securities directly.

No non-derivative share transactions were reported, and the filing was made individually by the director. The grant represents routine equity compensation designed to align director incentives with shareholder value, but it modestly increases the company鈥檚 fully diluted share count.

SEC Form 4 filed for First Guaranty Bancshares, Inc. (FGBI) discloses that director Edgar R. Smith III markedly increased his ownership on 30 June 2025.

• Open-market purchase: 30,865 common shares acquired at $8.10 (Code P).
• Debt-for-equity exchange: 1,981,506 new shares issued at $7.57 in exchange for a $15 million floating-rate subordinated note under an Exchange Agreement dated 16 June 2025.
• Note amendments: 88,482 shares issued at $8.00 to Smith & Tate Investments, LLC pursuant to amendments to an existing promissory note and a subordinated note.

Following these transactions, Smith reports 2,852,467 shares held directly. Indirectly, he controls additional positions through several LLCs, including Smith & Hood Holding Company, LLC (1,062,817 shares) and three other investment entities, taking total reported beneficial ownership well above three million shares.

The filing signals a net addition of roughly 2.1 million shares, replacing interest-bearing debt with equity and reflecting continued insider confidence. Because the new shares were issued below recent market purchases ($7.57 vs. $8.10), the company reduces debt at a valuation apparently acceptable to both parties while the director deepens alignment with common shareholders.

Form 4 snapshot: On 06/25/2025, Todd M. Duchene, Chief Legal and Administrative Officer of Core Scientific, Inc. (CORZZ), sold 7,759 common shares at $12.391 each. The sale鈥攙alued at roughly $96 thousand鈥攚as executed under a pre-existing instruction to cover withholding taxes triggered by the vesting of restricted stock units.

After the disposition, Duchene continues to hold 2,049,689 shares directly.

The filing also discloses that on 06/17/2025 he received 7,346 shares at no cost via an in-kind pro-rata distribution from shares reserved for claims settlement stemming from the company鈥檚 prior bankruptcy proceedings. That receipt was exempt from Section 16 reporting under Rule 16a-9.

No derivative transactions or additional insider trades were reported in this filing.